323 related articles for article (PubMed ID: 29549904)
1. Preoperative lymph node size is helpful to predict the prognosis of patients with stage III gastric cancer after radical resection.
Shang-Guan XC; Chen QY; Li P; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Huang CM; Zheng CH
Surg Oncol; 2018 Mar; 27(1):54-60. PubMed ID: 29549904
[TBL] [Abstract][Full Text] [Related]
2. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of extranodal extension in stage 1B gastric carcinomas.
Lee IS; Kang HJ; Park YS; Ryu MH; Yook JH; Kang YK; Kim BS
Surg Oncol; 2018 Jun; 27(2):299-305. PubMed ID: 29937185
[TBL] [Abstract][Full Text] [Related]
4. [Long-term efficacy of robotic radical total gastrectomy for gastric cancer and analysis of prognostic factors].
Xie SH; Shi Y; Long D; Chen J; Zhao YL; Qian F; Hao YX; Tang B; Li PA; Yu PW
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):357-363. PubMed ID: 32306603
[No Abstract] [Full Text] [Related]
5. Topographic lymph node staging system shows prognostic superiority compared to the 8th edition of AJCC TNM in gastric cancer. A western monocentric experience.
Lauricella S; Caricato M; Mascianà G; Carannante F; Carnazza M; Bonaccorso A; Angeletti S; Ciccozzi M; Coppola R; Capolupo GT
Surg Oncol; 2020 Sep; 34():223-233. PubMed ID: 32869748
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
[TBL] [Abstract][Full Text] [Related]
7. Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center.
Macalindong SS; Kim KH; Nam BH; Ryu KW; Kubo N; Kim JY; Eom BW; Yoon HM; Kook MC; Choi IJ; Kim YW
BMC Cancer; 2018 Jan; 18(1):73. PubMed ID: 29329569
[TBL] [Abstract][Full Text] [Related]
8. Does Noncompliance in Lymph Node Dissection Affect Oncological Efficacy in Gastric Cancer Patients Undergoing Radical Gastrectomy?
Chen QY; Zhong Q; Liu ZY; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Li P; Zheng CH; Huang CM
Ann Surg Oncol; 2019 Jun; 26(6):1759-1771. PubMed ID: 30756329
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study.
Chen L; Zhang C; Yao Z; Cui M; Xing J; Yang H; Zhang N; Liu M; Xu K; Tan F; Li Y; Jiang B; Su X
BMC Cancer; 2021 Aug; 21(1):974. PubMed ID: 34461860
[TBL] [Abstract][Full Text] [Related]
11. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
[No Abstract] [Full Text] [Related]
13. Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.
Wu XJ; Miao RL; Li ZY; Bu ZD; Zhang LH; Wu AW; Zong XL; Li SX; Shan F; Ji X; Ren H; Ji JF
Eur J Surg Oncol; 2015 Jul; 41(7):927-33. PubMed ID: 25913059
[TBL] [Abstract][Full Text] [Related]
14. Impact on survival of the number of lymph nodes resected in patients with lymph node-negative gastric cancer.
Chu X; Yang ZF
World J Surg Oncol; 2015 Jun; 13():192. PubMed ID: 26026805
[TBL] [Abstract][Full Text] [Related]
15. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
Bilici A; Selcukbiricik F
Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
[TBL] [Abstract][Full Text] [Related]
17. Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset.
Hayashi S; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
Gastric Cancer; 2019 Jul; 22(4):853-863. PubMed ID: 30483985
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the prognostic value of UICC and JGCA lymph node staging criteria for gastric cancer].
Pan Y; Liang H; Xue Q; Zhang RP; Cui QH; Liu N; Wang BG
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):376-80. PubMed ID: 18953840
[TBL] [Abstract][Full Text] [Related]
19. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH
Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506
[TBL] [Abstract][Full Text] [Related]
20. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]